GLP-1s and Beyond: Weight Loss Medications and Treatments Today – WebMD Workshop on Jan. 8Explore the range of obesity treatments on the market today; the benefits and side effects of GLP-1s; and how the market is shifting in 2026
DATE:January 8, 2026 TIME:1pm Eastern Standard Time / 10am Pacific EXPERT:Ariana M. Chao, PhD, CRNP, RN
Register for this workshop on obesity medications on Thursday, January 8, at 1pm ET. Sign up and receive the free replay link as well!
GLP-1 agonists are among the most consequential and impactful drug classes in recent history. Used to treat type 2 diabetes, obstructive sleep apnea, obesity, and more, injectable GLP-1s are hailed for their efficacy and their wide-reaching benefits.
In 2026, the availability and affordability of GLP-1s are poised to explode, with pill formulations on the horizon and expanded Medicare and Medicaid coverage. As the treatment landscape shifts beneath our feet, this timely webinar will help attendees:
Explore the full range of obesity treatments on the market today
Understand the mechanisms, benefits, and side effects associated with GLP-1 agonists
Recognize all indications and appropriate patients for GLP-1 agonists
Study the complementary lifestyle strategies recommended while taking GLP-1s
Understand the history of these medications and how the market is shifting in 2026 and beyond
Ariana M. Chao, PhD, CRNP, RN is an Associate Professor at the Johns Hopkins University School of Nursing who is internationally recognized for her leadership in obesity treatment.
Her program of research is focused on the development of innovative treatments for obesity and related eating behaviors that improve physical and mental health. She has published more than 100 articles and her work has been supported by the National Institutes of Health as well as foundation and industry sponsors.
